CHARACTERIZATION OF MELPHALAN-GLUTATHIONE ADDUCTS WHOSE FORMATION IS CATALYZED BY GLUTATHIONE TRANSFERASES

被引：182

作者：

DULIK, DM ^{[1
]}

FENSELAU, C ^{[1
]}

HILTON, J ^{[1
]}

机构：

[1] JOHNS HOPKINS UNIV,SCH MED,CTR ONCOL,BALTIMORE,MD 21205

来源：

BIOCHEMICAL PHARMACOLOGY | 1986年 / 35卷 / 19期

关键词：

D O I：

10.1016/0006-2952(86)90444-2

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：3405 / 3409

页数：5

共 13 条

[1]

EVANS TL, 1982, CANCER CHEMOTH PHARM, V8, P175

[2]

FAIRLAMB AH, 1985, SCIENCE, V227, P1495

[3]

FENSELAU C, 1978, PHYSICAL METHODS MOD, V1, P123

[4]

FURNER RL, 1976, DRUG METAB DISPOS, V4, P577

[5]

GOLDENBERG GJ, 1984, HDB EXPT PHARM ANTIT, P198

[6]

Habig WH, 1974, J BIOL CHEM, V249, P7120

[7] AUGMENTATION OF ADRIAMYCIN, MELPHALAN, AND CISPLATIN CYTO-TOXICITY IN DRUG-RESISTANT AND DRUG-SENSITIVE HUMAN OVARIAN-CARCINOMA CELL-LINES BY BUTHIONINE SULFOXIMINE MEDIATED GLUTATHIONE DEPLETION [J].

HAMILTON, TC ;

WINKER, MA ;

LOUIE, KG ;

BATIST, G ;

BEHRENS, BC ;

TSURUO, T ;

GROTZINGER, KR ;

MCKOY, WM ;

YOUNG, RC ;

OZOLS, RF .

BIOCHEMICAL PHARMACOLOGY, 1985, 34 (14) :2583-2586

[8]

LEHMAN JP, 1981, DRUG METAB DISPOS, V9, P15

[9]

PALLANTE SL, 1986, DRUG METAB DISPOS, V14, P313

[10]

POHL LR, 1981, DRUG METAB DISPOS, V9, P334

← 1 2 →